FDA grants fast track status to Heidelberg Pharma’s Amanitin-based ADC candidate for multiple myeloma

The Fast Track Designation was supported by nonclinical data as well as clinical results from the ongoing Phase I/IIa trial evaluating the safety and tolerability

Sigachi Industries posts Q2 FY2026 consolidated profit at Rs. 10.68 Cr

Sigachi Industries has reported total income of Rs. 112.97 crore during the period ended September 30, 2025

Dr Reddys Laboratories reports Q2 FY26 consolidated PAT at Rs. 1,437.2 Cr

Dr Reddys Laboratories has reported total income of Rs. 8,805.1 crore during the period ended September 30, 2025

GSK acquires rights to prostate-cancer candidate from Syndivia for up to £268 million

Agreement adds a new preclinical ADC with potential for enhanced anti-tumour activity and best-in-class profile

Quest Diagnostics reports strong third quarter 2025 results and raises full-year guidance

Revenues up 13.1% year-over-year; Continued momentum driven by organic growth, strategic partnerships, and acquisitions

Laurus Labs posts Q2 FY26 consolidated PAT higher at Rs. 195 Cr

Laurus Labs has reported total income of Rs. 1,680.43 crore during the period ended September 30, 2025

Lupin to build $250 million manufacturing facility in Florida

Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?

Sai Life Sciences opens dedicated facility for veterinary APIs in Bidar

Cadila launches nutritional replenisher ‘Nu Nutridac’ capsule

Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders

Mankind Pharma gets CDSCO nod to begin Phase 1 trials of novel Autoimmune drug candidate MKP11093

MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile